MedPath

RECKITT BENCKISER HEALTHCARE (UK) LIMITED

🇬🇧United Kingdom
Ownership
-
Employees
-
Market Cap
-
Website

Ibuprofen Bioavailability Study

First Posted Date
2017-06-08
Last Posted Date
2017-10-05
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
36
Registration Number
NCT03180879
Locations
🇬🇧

Simbec Research, Merthyr Tydfil, United Kingdom

Naproxen Sodium (2 x 220 mg) Fasted Comparative Bioavailability Study

Phase 1
Completed
Conditions
Healthy
Interventions
Drug: Test
Drug: Reference
First Posted Date
2017-05-30
Last Posted Date
2019-02-28
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
18
Registration Number
NCT03167541

A 24 Hour Occlusive Single Patch Test to Assess Acute Tolerance of Pre Lubricated Condom on a Panel of Healthy Adult Subjects

Not Applicable
Completed
Conditions
Healthy
Interventions
Device: Condom
First Posted Date
2016-08-12
Last Posted Date
2016-09-09
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
33
Registration Number
NCT02864966
Locations
🇬🇧

Alba Science Ltd, Edinburgh, United Kingdom

To Evaluate the in Use Tolerance of E45 Eczema Repair Emollient in Babies and Children With (Very(Dry/Atopic Skin

Not Applicable
Completed
Conditions
Atopic Dermatitis / Eczema
Interventions
Device: E45 Eczema Repair Emollient
First Posted Date
2016-08-05
Last Posted Date
2017-02-08
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
34
Registration Number
NCT02857062

Compound Sodium Alginate Oral Suspension Sachet Symptomatic Relief Study

Phase 3
Completed
Conditions
Gastro-esophageal Reflux Disease (GERD)
Interventions
Drug: Matched placebo
Drug: Compound Sodium Alginate Oral Suspension sachet
First Posted Date
2015-12-07
Last Posted Date
2016-06-03
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
644
Registration Number
NCT02623062
Locations
🇨🇳

The First Affilated Hospital Sun Yat-Sen University, Guangzhou, Guangdong, China

A 47 Hour Occlusive Cutaneous Skin Patch Test on Adult Subjects With Dry/Atopic Skin

Phase 1
Completed
Conditions
Eczema
Interventions
Device: Eczema Repair Emollient
First Posted Date
2015-12-03
Last Posted Date
2016-06-03
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
33
Registration Number
NCT02620293
Locations
🇩🇪

Skin Investigation Technology, Hamburg, Germany

Compound Sodium Alginate Oral Suspension Sachet 4-hour Esophageal pH Study in GERD Patients

Phase 3
Terminated
Conditions
Gastro-esophageal Reflux Disease (GERD)
Interventions
Drug: Compound Sodium Alginate Oral Suspension sachet
Drug: Matched placebo
First Posted Date
2015-12-02
Last Posted Date
2017-10-06
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
16
Registration Number
NCT02619747
Locations
🇨🇳

The First Affilated Hospital Sun Yat-Sen University, Guangzhou, Guangdong, China

Evaluation of the Performance of a Fungal Nail Treatment on the Visual Signs of Onychomycosis

Not Applicable
Completed
Conditions
Onychomycosis of Toenails
Interventions
Device: A Fungal Nail Treatment
First Posted Date
2015-09-10
Last Posted Date
2017-04-11
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
60
Registration Number
NCT02546258
Locations
🇬🇧

Intertek CRS, Manchester, United Kingdom

Ibuprofen Suspension Bioequivalence Study

Phase 1
Completed
Conditions
Healthy Volunteer Study
Interventions
Drug: Algifor Dolo Junior®
Drug: Nurofen for Children®
First Posted Date
2015-07-20
Last Posted Date
2018-04-13
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
28
Registration Number
NCT02503085
Locations
🇬🇧

Reckit Benckiser, Hull, United Kingdom

Ibuprofen and Paracetamol Pharmacokinetic Study

First Posted Date
2015-05-22
Last Posted Date
2015-05-27
Lead Sponsor
Reckitt Benckiser Healthcare (UK) Limited
Target Recruit Count
43
Registration Number
NCT02452450
© Copyright 2025. All Rights Reserved by MedPath